Loading clinical trials...
Loading clinical trials...
Investigating Oleoylethanolamide (OEA) as a Novel Multi-System Based Therapeutic for Young Adults With Alcohol Use Disorder
Conditions
Interventions
oleoylethanolamide
Locations
1
United States
Medical University of South Carolina
Charleston, South Carolina, United States
Start Date
June 1, 2026
Primary Completion Date
March 31, 2031
Completion Date
March 31, 2031
Last Updated
March 31, 2026
NCT06804525
NCT07071779
NCT07217795
NCT06303778
NCT06696365
NCT06987526
Lead Sponsor
Medical University of South Carolina
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions